• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CMAJ - MB Cume Incidence Rate for Pregnant Women

cartski

Advisory Board
Estimated cumulative incidence of pandemic (H1N1) influenza among pregnant women during the first wave of the 2009 pandemic

http://www.cmaj.ca/cgi/content/abstract/cmaj.100488v1

Salaheddin M. Mahmud 1, Marissa Becker 2, Yoav Keynan 3, Lawrence Elliott 2, Laura H. Thompson 1, Keith Fowke 2, Lisa Avery 1, Paul Van Caeseele 4, Sande Harlos 1, James Blanchard 1, Magdy Dawood 4
1 The Department of Community Health Sciences, University of Manitoba, Winnipeg, Man.
2 The Departments of Community Health Sciences and Medical Microbiology, University of Manitoba, Winnipeg, Man.
3 The Department of Medical Microbiology, University of Manitoba, Winnipeg, Man.
4 The Department of Medical Microbiology, University of Manitoba, Winnipeg, Man.; the Cadham Provincial Laboratory, Winnipeg, Man.


Abstract


Background:

Hospitalization and lab confirmed cases of H1N1 have been reported during the first wave of the 2009 pandemic but these are not accurate measures of influenza incidence in the population. We estimated the cumulative incidence of pandemic (H1N1) influenza among pregnant women in the province of Manitoba during the first wave of the 2009 pandemic.

Methods:

Two panels of stored frozen serum specimens collected for routine prenatal screening were randomly selected for testing before (March 2009, n = 252) and after (August 2009, n = 296) the first wave of the pandemic. A standard hemagglutination inhibition assay was used to detect the presence of IgG antibodies against the pandemic (H1N1) 2009 virus. The cumulative incidence of pandemic (H1N1) influenza was calculated as the difference between the point prevalence rates in the first and second panels.

Results:

Of the specimens collected in March, 7.1% were positive for the IgG antibodies (serum antibody titre 1:40). The corresponding prevalence was 15.7% among the specimens collected in August. The difference indicated a cumulative incidence of 8.6% (95% confidence interval [CI] 3.2%?13.7%). The rate differed geographically, the highest being in the northern regions (20.8%, 95% CI 7.9%?31.8%), as compared with 4.0% (95% CI 0.0%?11.9%) in Winnipeg and 8.9% (95% CI 0.0%?18.8%) in the rest of the province.

Interpretation:

We estimated that the cumulative incidence of pandemic (H1N1) influenza among pregnant women in Manitoba during the first wave of the 2009 pandemic was 8.6%. It was 20.8% in the northern regions of the province.


http://www.cmaj.ca/cgi/content/abstract/cmaj.100488v1
 
Back
Top Bottom